logo

For the Inventor, By the Inventor

Springboro, OH, United States of America

Matthew B Maier

This inventor holds 16 USPTO granted patents and 5 published patent applications, primarily in Protein Phosphatase Inhibitors. Top assignees: Aerpio Therapeutics, Inc., The Procter Gamble Company, Warner Chilcott Company, LLC. Active years: 2009-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matthew B Maier. Retrieved from https://idiyas.com/inventor/matthew-b-maier

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 16 

% Patents Active = 50.0

Average Co-Inventor Count = 5.0

ph-index = 15

Forward Citations = 576(Granted Patents)


Location History:

  • Springboro, OH (US) (2009 - 2017)
  • Chesapeake, VA (US) (2019)

Company Filing History:

goldMedal11 out of 35 
 
Aerpio Therapeutics, Inc.
 patents
silverMedal2 out of 17,692 
 
The Procter Gamble Company
 patents
bronzeMedal2 out of 39 
 
Warner Chilcott Company, LLC
 patents
4. 1 out of 8 
 
Aerpio Pharmaceuticals, Inc.
 patents

Years Active: 2009-2019

Loading Chart...
Areas of Expertise:
Protein Tyrosine Phosphatase
Inhibitors
Therapeutic Applications
Human Proteins
Biochemistry
Pharmaceuticals
Drug Development
Enzyme Regulation
Molecular Biology
Biotechnology
Targeted Therapy
Cancer Treatment
16 patents (USPTO):Explore Patents
1. 10463650 - Human protein tyrosine phosphatase inhibitors and methods of use (2019-11-05),
2. RE46592 - Human protein tyrosine phosphatase inhibitors and methods of use (2017-10-30),
3. 9795594 - Human protein tyrosine phosphatase inhibitors and methods of use (2017-10-24),
4. 9284285 - Human protein tyrosine phosphatase inhibitors and methods of use (2016-03-15),
5. 9126958 - Human protein tyrosine phosphatase inhibitors and methods of use (2015-09-08),
6. 8946232 - Human protein tyrosine phosphatase inhibitors and methods of use (2015-02-03),
7. 8895563 - Human protein tyrosine phosphatase inhibitors and methods of use (2014-11-25),
8. 8846685 - Human protein tyrosine phosphatase inhibitors and methods of use (2014-09-30),
9. 8338615 - Human protein tyrosine phosphatase inhibitors and methods of use (2012-12-25),
10. 8329916 - Human protein tyrosine phosphatase inhibitors and method of use (2012-12-11),
11. 8258311 - Human protein tyrosine phosphatase inhibitors and methods of use (2012-09-04),
12. 8188125 - Human protein tyrosine phosphatase inhibitors and methods of use (2012-05-29),
13. 8106078 - Human protein tyrosine phosphatase inhibitors and methods of use (2012-01-31),
14. 7795444 - Human protein tyrosine phosphatase inhibitors and methods of use (2010-09-14),
15. 7622593 - Human protein tyrosine phosphatase inhibitors and methods of use (2009-11-24),

Title: The Inventor Matthew B Maier: Pioneering Innovations in Springboro, OH

Introduction: Matthew B Maier is a distinguished inventor based in Springboro, Ohio, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Matthew B Maier's latest patents include cutting-edge technologies in the fields of renewable energy, sustainable agriculture, and advanced robotics, showcasing his commitment to addressing pressing global challenges.

Career Highlights: With a career spanning over two decades, Matthew B Maier has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing solutions that push the boundaries of what is possible.

Collaborations: Throughout his career, Matthew B Maier has collaborated with leading research institutions, universities, and forward-thinking companies to bring his inventions to life, fostering a culture of innovation and excellence in every project he undertakes.

Conclusion: Matthew B Maier's relentless pursuit of innovation and his passion for creating a positive impact on society have solidified his reputation as a trailblazing inventor in Springboro, Ohio, and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…